Twenty-two phthalazine derivatives are designed, synthesized, and assessed against four human CA isoforms, showing notable activity against hCA IX and hCA I. Selective compounds exhibit a selectivity index up to 13.8. Docking analysis reveals active site interactions, and anticancer effects are tested on two breast cancer cell lines.
设计、合成了 22 种二氮杂
萘衍
生物,并针对四种人 CA 异构体进行了评估,显示出针对 hCA IX 和 hCA I 的显着活性。选择性化合物的选择性指数高达 13.8。对接分析揭示了活性位点相互作用,并在两种乳腺癌
细胞系上测试了抗癌作用。